Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

PhRMA Statement on House Vote to Repeal IPAB

November 2, 2017

PhRMA applauds the House for taking much needed action to repeal the Independent Payment Advisory Board (IPAB). This Board of unelected bureaucrats was given virtually unchecked power to make decisions that impact more than 55 million Medicare beneficiaries – overruling Congress’ authority over the Medicare program and threatening patient access to needed medicines.

Read More

Biopharmaceutical Leaders: Japanese Patients, Health Care System and Economy Benefit from Access to Innovative Medicines

November 1, 2017

Leaders from US -based innovative biopharmaceutical companies met with Japanese government officials and other stakeholders October 30-November 1 to underscore the importance of the country’s critical role as a pro-innovation economy.

Read More

A new era in cancer

November 1, 2017

A new era in medicine is revolutionizing how we diagnose, treat and hopefully one day cure the many diseases that make up cancer.

Read More

Medicare Monday: CMS withdraws Part B demo, takes positive step forward on CMMI

October 30, 2017

CMS withdrawal of Part B demo and RFI on future of CMMI mark steps in the right direction for agency.

Read More

PhRMA Statement on Trump Opioids Announcement

October 26, 2017

Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl issued the following statement.

Read More

Disease modifying therapies for the management of multiple sclerosis save money and improve patient outcomes

October 24, 2017

In this post, we feature a study comparing the effectiveness of oral and injectable disease-modifying therapies (DMTs) for multiple sclerosis (MS) patients.

Read More

PhRMA letter to Puerto Rico Secretary of Economic Development and Commerce

October 23, 2017

On behalf of our members, PhRMA wants to thank you for your leadership in the recovery efforts in Puerto Rico after two recent hurricanes – most notably Hurricane Maria – struck the island last month.

Read More

340B Spotlight: ICYMI – 340B hearing, new reports highlight growing need for program reform

October 20, 2017

Evidence that the 340B program has strayed from its congressionally stated intent has been piling up.

Read More

The Washington Post retracts PhRMA claim in opioid story

October 18, 2017

Earlier this week, the Washington Post falsely claimed that the PhRMA supported the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

Read More

Excerpts from testimony by PhRMA’s Lori Reilly

October 17, 2017

Lori Reilly, executive vice president for policy, research &membership at PhRMA, testified at the U.S. Senate Committee on Health, Education Labor and Pensions.

Read More